Abstract
Pathogenic germ line heterozygous variants in MECOM (myelodysplastic syndrome[MDS]1 and EVI1 complex locus) are associated with an autosomal dominant bone marrow failure (BMF) disorder characterized by radioulnar synostosis (RUS) often accompanied by amegakaryocytic thrombocytopenia (RUSAT2; Mendelian Inheritance in Man number 616738). MECOM is a transcription factor that is essential for hematopoietic stem cell self-renewal, and the loss of MECOM decreases absolute long term hematopoietic stem cell numbers.1 Several differentially spliced transcripts are encoded by the MECOM locus resulting in MDS1, MDS1-EVI1, and EVI1 isoforms. It has been demonstrated that these isoforms are involved in their own transcriptional regulation through distinct promoter regions and have an effect on the maintenance and transformation of hematopoietic stem and progenitor cell populations.
| Original language | English |
|---|---|
| Pages (from-to) | 3437-3443 |
| Number of pages | 7 |
| Journal | Blood Advances |
| Volume | 8 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 9 Jul 2024 |
Keywords
- MECOM
- myelodysplastic syndrome
- EVI1 complex locus
- autosomal dominant bone marrow failure
- somatic genetics
- Pathogenic germ line heterozygous variants
- clonal hematopoiesis
- phenotype expansion
Fingerprint
Dive into the research topics of 'Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver